Cooper Institute for Reproductive Hormonal Disorders, PC

What the CDC NASS Data Shows for Cooper Institute for Reproductive Hormonal Disorders, PC

Cooper Institute for Reproductive Hormonal Disorders, PC reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 670 total ART cycles, split between 372 fresh and 298 frozen embryo transfer cycles. The overall success rate — live births per cycle started — was 16.4%. That is 17.8 percentage points below the New Jersey state average of 34.2%, which may reflect a more complex patient case mix rather than quality of care.

Age remains the dominant variable in IVF outcomes. At Cooper Institute for Reproductive Hormonal Disorders, PC, patients under 35 saw a 33.3% success rate, compared with 24.1% for ages 35–37 and 10.7% for ages 38–40. The over-40 cohort reported 2.2%. Single embryo transfer (SET) was used in 31.6% of cycles, a metric ASRM associates with lower multi-pregnancy rates.

Service availability also affects which clinics fit which patients. Cooper Institute for Reproductive Hormonal Disorders, PC does report donor egg services and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary — PlainFertility is not affiliated with Cooper Institute for Reproductive Hormonal Disorders, PC or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.

Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer — a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.